Mr. Nikhil Chopra, CEO & Whole-Time Director, JB Pharma A Year of Market-Beating Growth, Superior Performance and an Optimistic Outlook towards a Promising Future Mumbai (Maharashtra) [India], June 6: JB Pharma, the fastest-growing company in the Indian Pharmaceutical Market, today marks the one-year anniversary of the launch of its identity. Good People for Good Health is […]
Continue Reading
Profit after Tax stood at Rs. 106 crore as compared to Rs. 84 crore registering growth of 26% Mumbai (Maharashtra) [India], February 13: JB Pharma, one of the fastest growing pharmaceutical companies in India, announced record revenue growth of 32% to Rs. 793 crore in Q3 FY23. Operating EBITDA (Earnings Before Interest Depreciation and Taxes) […]
Continue Reading
Operating EBITDA* grew by 44% to INR 202 crores Mumbai (Maharashtra) [India], November 12: JB Pharma, one of the fastest growing pharmaceutical companies in India continued on its strong growth momentum, announced its financial results for the second quarter ended 30th September 2022, registering YoY growth of 36% in Q2 FY23 and 33% in H1 […]
Continue Reading
JB Pharma’s initiative – #Heart2HeartChallengeIndia aims to spread awareness about heart health amongst the masses as a study demonstrated if one takes more than one-and-a-half minutes to climb four floors of stairs, one’s heart is suboptimal Delhi/Mumbai, September 23, 2022: World Heart Day (WHD) – September, 29 is a gentle reminder to look into whether our […]
Continue Reading